Clinical Trials Browser

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Phase 1/2 Unknown

16 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT01919866 2014-10-08

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

Phase 1/2 Unknown

120 enrolled

Classical hematology

Anemia, Aplastic

NCT02007811 2014-03-26

B-cell therapy

Phase 1/2 Unknown

15 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00895739 2013-08-12

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Phase 2 Unknown

50 enrolled

Classical hematology

Anemia, Aplastic, Neoplasms

NCT00737685 2012-03-26

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

Phase 2 Unknown

30 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Clinical Trials

ToTem

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

B-cell therapy

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)